NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced SUN SILVER LTD. (ASX: SS1; OTCQX: SSLVF), an Australian exploration company, has qualified to trade on the OTCQX® Best Market. SUN SILVER LTD. upgraded to OTCQX from the Pink® market. SUN SILVER LTD. begins trading today on OTCQX under the symbol “SSLVF.” U.S. investors can find current financial disclosure and Real-Time Level 2 ...

CALGARY, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) -- TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) announced today that John Kousinioris, President and Chief Executive Officer and a Director of TransAlta, plans to retire effective April 30, 2026. Concurrent with this announcement, the Board of Directors (Board) has appointed Joel Hunter, TransAlta’s Executive Vice President, Finance and Chief Financial Officer, to succeed Mr. Kousinioris as President and Chief Executive Officer and b ...

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’; Nasdaq: MRX) a diversified global financial services platform, providing essential liquidity, market access and infrastructure services to clients in the energy, commodities and financial markets, today reported financial results for the third quarter ('Q3 2025'). Ian Lowitt, Group Chief Executive Officer, stated, “I’m pleased to report strong third quarter financial results at the top end of our previously announced prelim ...

Raw Garden Live Resin Terpene Cartridges and All-in-One Vapes will be sold at Verano’s Four New Jersey Zen Leaf dispensaries and third-party retailers beginning November 11th. CHICAGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced an exclusive partnership with Raw Garden, a cultivator and producer of pure cannabis products balancing flavor and potency, to bring a suite of the Californ ...

End of Period Subscribers of 3.0 million, including Clinical Subscribers of 124 thousand Total Revenues of $172 million; Clinical Subscription Revenues of $26 million, up 35% year-over-year Net Loss of $58 million; Net Loss Margin of 33.4%; Adjusted EBITDA1 of $43 million and Adjusted EBITDA Margin1 of 24.9% Narrowing 2025 Guidance to the higher end of previous ranges for Revenue and Adjusted EBITDA1 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“WeightWatchers,” “WW,” o ...

Second agreement signed with Novartis to develop novel degraders for immune-mediated diseases, providing upfront payment of $120 million plus option maintenance payments, and eligibility for option exercise payments, milestones, and tiered royalties Phase 1 study of NEK7-directed MGD MRT-8102 underway, investigating a potential novel approach to treat inflammatory diseases driven by the NLRP3 inflammasome; initial readout including data from high-CVD risk cohort on track for H1 2026 VAV1-directed MGD MRT-61 ...

- Positive Results from Phase 2a Trial of ITK/JAK3 Inhibitor ATI-2138 Presented at the 2025 European Academy of Dermatology and Venereology (EADV) Congress, Further Validating ITK as Therapeutic Target; Initiation of Phase 2 Trial in an Additional Indication Expected in the First Half of 2026 - - Timelines Reiterated for Top Line Clinical Results from Ongoing Trials of Investigational Anti-TSLP Monoclonal Antibody Bosakitug (ATI-045) and Anti-TSLP/IL-4R Bispecific Antibody ATI-052 - - Initiation of Phase 1b ...

NEW YORK, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the third quarter ended September 30, 2025. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: "We are pleased with our third quarter results that reflect investments in sales and marketing, continued progress in our executional capabilities and the early results of our latest new product introductions. We are reaffirming our annual guidance an ...

WEST PALM BEACH, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Onity Group Inc. (NYSE: ONIT) (“Onity” or the “Company”) today announced its third quarter 2025 results and provided a business update. Third Quarter 2025: Net income attributable to common stockholders of $18 million; diluted EPS of $2.03; ROE of 14%Adjusted pre-tax income* of $31 million, resulting in annualized adjusted ROE* of 25%Book value per share improved to $62 as of September 30, 2025, up $2.71 YoYOriginations volume of $12 billion, up 39% Y ...

核心观点 - 公司公布2025年第三季度财务业绩 尽管净亏损5900万美元 但管理层强调在业务简化、资本回收和战略执行方面取得进展 并看好公司内在价值的持续增长 [1][2] - 公司正在进行企业结构简化 计划将所有合伙单位及可交换股份转换为新上市公司股份 该计划已获得特别委员会和董事会的一致推荐 预计于2026年第一季度完成 [12][15][16] 财务业绩摘要 - 2025年第三季度归属于单位持有人的净亏损为5900万美元（每单位亏损0.28美元） 而去年同期为净利润3.01亿美元（每单位收益1.39美元） [2] - 本季度调整后税息折旧及摊销前利润为5.75亿美元 低于去年同期的8.44亿美元 主要原因是去年同期高级能源存储业务录得2.96亿美元的税收抵免 而本期仅为7700万美元 且本期资产处置收益较低 [2][3] - 2025年前九个月调整后税息折旧及摊销前利润为17.57亿美元 去年同期为19.12亿美元 [2][3] - 公司季度末拥有约23亿美元流动性 在宣布及近期完成交易后 预计流动性将增至约29亿美元 [18] 分部门运营表现 - 工业部门调整后税息折旧及摊销前利润为3.16亿美元 若剔除税收抵免影响 较去年同期增长17% 增长动力来自2025年1月收购的电伴热系统制造商以及高级能源存储业务因销量增长和产品组合向高利润率先进电池倾斜带来的强劲表现 [4][5] - 商业服务部门调整后税息折旧及摊销前利润为1.88亿美元 受到2025年7月出售经销商软件与技术服务业务部分权益的影响 住宅抵押贷款保险公司受益于首次购房者等细分市场的韧性需求 [6][7] - 基础设施服务部门调整后税息折旧及摊销前利润为1.04亿美元 反映了2025年1月处置海上石油服务穿梭油轮业务及7月出售工作通道服务业务部分权益的影响 模块化建筑租赁服务在终端市场疲软下通过增值产品和服务销售保持稳定表现 [8][9] 战略举措与公司行动 - 资本回收方面 海上石油服务业务于9月达成出售其浮式生产储卸油装置业务的协议 预计交易于2026年上半年完成 结合此前资产出售收益 有望回收大部分投入资本 [10] - 资本部署方面 公司于10月以26亿美元完成对加拿大领先住宅和多户住宅抵押贷款机构First National Financial Corporation的私有化 公司投资1.46亿美元获得11%权益 [11] - 公司宣布每股0.0625美元的季度分派 将于2025年12月31日支付给2025年11月28日登记在册的单位持有人 [19]